Verizon stock price ticks higher as Frontier deal closes; what VZ investors watch next
20 January 2026
1 min read

Verizon stock price ticks higher as Frontier deal closes; what VZ investors watch next

NEW YORK, Jan 20, 2026, 14:48 EST — Regular session

  • Verizon shares ticked up roughly 0.4% following the completion of its Frontier acquisition
  • SEC filing reveals Frontier shareholders will receive $38.50 in cash per share
  • Traders are now eyeing the January 30 earnings report for updates on integration and spending details

By 2:48 p.m. EST Tuesday, Verizon Communications Inc shares had risen roughly 0.4% to $39.07, following the closing of its cash acquisition of Frontier Communications Parent, according to an SEC filing. AT&T shares slipped about 0.2%, while T-Mobile US dropped around 0.6%. Frontier shareholders will receive $38.50 per share in cash, the filing stated. 1

The closing matters because it pushes Verizon deeper into fixed broadband, where fiber lines carry more data than older copper networks. Carriers favor bundling home internet with mobile plans since it helps reduce churn — the industry term for customers leaving.

The timing is tricky for major U.S. telecoms: promotions have returned, and investors are pressing for clarity on the balance between protecting subscribers and maintaining cash flow. Verizon’s upcoming earnings report will probably serve as the first concrete measure of how the Frontier integration is shaping up.

Chief executive Dan Schulman told employees the merger “immediately creates an unparalleled fiber network” and noted that Verizon’s coverage now extends to roughly 30 million “fiber passings”—addresses eligible for fiber service. 2

In September 2024, Verizon struck a deal to acquire Frontier for roughly $20 billion, debt included. California regulators gave the green light on Jan. 15, following Verizon’s agreement to specific broadband rollout and service conditions, according to Reuters. 3

The Frontier close comes amid renewed questions about reliability. Verizon said Tuesday that last week’s major outage was caused by a software issue and confirmed it had “no indication” of a cybersecurity attack. Downdetector recorded over 2.3 million user reports on Jan. 14, per the same report. Meanwhile, MoffettNathanson analyst Craig Moffett noted in a Tuesday memo that it’s “less clear” if Schulman will push for a faster Frontier fiber rollout while also investing heavily in wireless promotions. 4

But the Frontier wager carries execution risks that defy easy summarization in a slide deck. Merging systems and field operations is a slow process, and regulatory conditions tied to approvals may force sustained capital spending if wireless price pressures persist.

Telecom investors usually focus on Verizon’s cash flow and dividend safety, not high-growth stories. So, they’re quick to react if integration expenses start climbing faster than anticipated.

Verizon plans to release its fourth-quarter 2025 earnings on Jan. 30, with a webcast set for 8:00 a.m. Eastern, the company announced. Investors will focus on guidance for 2026 spending, progress on integration efforts, and management’s take on Frontier—whether it remains a short-term cash drag or a faster route to stable broadband growth. 5

Verizon’s stock will probably react to any updates on integration and fresh moves by regulators investigating the outage until then.

Stock Market Today

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Stock Market Today 08.02.2026

8 February 2026
LIVEMarkets rolling coverageStarted: February 8, 2026, 12:00 AM ESTUpdated: February 8, 2026, 12:19 AM EST Sprinklr (CXM) Undervalued Amid Share Price Drop, AI Growth Potential Assessed February 8, 2026, 12:11 AM EST. Sprinklr (CXM) shares hover near $6, reflecting a 21% drop over 30 days and nearly 31% decline year-to-date. Despite negative returns stretching back three years, some analysts see an intrinsic value of around $11, suggesting the stock may be undervalued. The AI-driven customer experience platform is integrating advanced AI functionalities across marketing and customer service products to capitalize on rising demand for AI-powered analytics. Key risks include potential
Tower Semiconductor stock jumps again on Nvidia optics tie-up as earnings near

Tower Semiconductor stock jumps again on Nvidia optics tie-up as earnings near

8 February 2026
Tower Semiconductor shares rose 7.7% to $139.04 Friday after announcing a collaboration with Nvidia on AI data-center networking. The stock touched $141 intraday and gained another 1% after hours. Investors await Tower’s Feb. 11 earnings for details on its silicon photonics work. No financial terms or shipment timeline were disclosed.
Longsys Electronics stock heads into Monday after new guarantees; what 301308 investors watch next

Longsys Electronics stock heads into Monday after new guarantees; what 301308 investors watch next

8 February 2026
Longsys disclosed new guarantees for a 100 million yuan Hong Kong loan and a $9 million Brazil credit line, bringing its total approved guarantee quota to 11 billion yuan and outstanding guarantees to 5.81 billion yuan. The company said all guarantees are for consolidated subsidiaries and within approved limits. Shares closed at 288 yuan Friday, down 1.6%. China inflation and credit data are due this week.
MACOM stock price steadies near highs into Monday after earnings pop and fresh filings

MACOM stock price steadies near highs into Monday after earnings pop and fresh filings

8 February 2026
MACOM shares rose 3.5% to $235.87 Friday after the company reported fiscal Q1 revenue of $271.6 million and raised its full-year data center growth outlook to 35–40%. Fidelity’s FMR LLC disclosed a 10.7% stake, while shareholder Susan Ocampo filed to potentially sell up to 100,000 shares. Stifel raised its price target to $255. MACOM expects to repay $161 million in convertible notes in March.
Boston Scientific stock rises as BSX teases new pain-therapy data while FDA stent alert hangs over shares
Previous Story

Boston Scientific stock rises as BSX teases new pain-therapy data while FDA stent alert hangs over shares

Pfizer stock slips today as $1.9 billion ViiV exit and Novavax Matrix‑M deal land
Next Story

Pfizer stock slips today as $1.9 billion ViiV exit and Novavax Matrix‑M deal land

Go toTop